ConductScience.org, home

Trial · NCT04400487

Participant flow13

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Screening Period (28 Days)STARTEDVoxelotor25
Screening Period (28 Days)COMPLETEDVoxelotor25
Screening Period (28 Days)NOT COMPLETEDVoxelotor0
Run-in Period (14 Days)STARTEDVoxelotor25
Run-in Period (14 Days)COMPLETEDVoxelotor25
Run-in Period (14 Days)NOT COMPLETEDVoxelotor0
Treatment Period (24 Weeks)STARTEDVoxelotor25
Treatment Period (24 Weeks)Treated (With at Least 1 Dose of Study Treatment)Voxelotor25
Treatment Period (24 Weeks)COMPLETEDVoxelotor23
Treatment Period (24 Weeks)NOT COMPLETEDVoxelotor2
Follow-up Period (28 Days)STARTEDVoxelotor23
Follow-up Period (28 Days)COMPLETEDVoxelotor21
Follow-up Period (28 Days)NOT COMPLETEDVoxelotor2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04400487/flow